|
Corporate News
10-Dec-21
|
|
|
|
|
|
|
Alembic Pharmaceuticals invests in RIGImmune Inc.
|
|
|
|
Alembic Pharmaceuticals (Alembic) has announced today that it has made strategic investment in RIGlmmune Inc., a biopharmaceutical research company co-founded by two prominent Yale University professors.
RIGlmmune Inc. was founded by Dr. Anna Pyle and Dr. Akiko Iwasaki. Dr. Pyle is a Professor of Molecular, Cellular and Developmental Biology at Yale University and an investigator for the Howard Hughes Medical Institute. She is a pioneer in the field of RNA biochemistry. Dr. Akiko Iwasaki is a Professor in the Department of Immunology and a Professor of Molecular, Cellular, and Developmental Biology at Yale University.
She is also an investigator for the Howard Hughes Medical Institute and a pioneer in the field of immunology.
RIGlmmune Inc. is focused on the development of RNA based therapies for viral diseases and oncology applications by targeting the innate
immune target, RIG-I. RIGlmmune will utilize the proceeds of the series· seed round to further the development of therapeutic oligonucleotides developed by Dr. Pyle and Dr. Iwasaki.
Alembic has acquired preferred stock in RIGlmmune amounting to a 19.97% post money stake in the first closing of the series seed round that was completed recently.
|
|
Previous News |
Stock Alert: Alembic Pharma, Bajel Projects, Zydus Lifesciences, Lupin, Adani Enterprises, Biocon
(
Market Commentary
-
Stock Alert
30-Sep-24
08:34
)
|
|
Indices trade with major losses; VIX climbs 6.82%
(
Market Commentary
-
Mid-Session
02-Aug-24
12:34
)
|
|
Intellect Design Arena Ltd leads losers in 'A' group
(
Hot Pursuit
-
10-May-24
15:00
)
|
|
Alembic Pharma gets USFDA nod for Betamethasone Valerate Foam
(
Hot Pursuit
-
24-Aug-24
16:59
)
|
|
Alembic Pharmaceuticals receives USFDA approval for Betamethasone Valerate Foam
(
Corporate News
-
24-Aug-24
14:03
)
|
|
Alembic Pharma gets USFDA nod for Doxycycline Capsules
(
Hot Pursuit
-
28-Jun-24
12:20
)
|
|
CRISIL reaffirms ratings of Alembic Pharmaceuticals with 'stable' outlook
(
Hot Pursuit
-
08-Mar-24
11:22
)
|
|
Alembic Pharmaceuticals receives USFDA's tentative approval for Acalabrutinib Capsules
(
Corporate News
-
19-Jan-23
14:19
)
|
|
Alembic Pharma’s Gujarat unit gets EIR from USFDA
(
Hot Pursuit
-
28-Sep-24
13:02
)
|
|
Alembic Pharma gets US FDA nod for cancer treatment drug Nelarabine
(
Hot Pursuit
-
02-Aug-24
11:26
)
|
|
Alembic Pharmaceuticals consolidated net profit rises 48.01% in the December 2023 quarter
(
Results
-
Announcements
05-Feb-24
14:52
)
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|